Journal of Oncology and Cancer Research

Dr. Carlo Ronsini is an Italian gynecologic oncologist and surgeon currently serving as Head Physician of Gynecologic Oncology at the National Cancer Institute IRCCS Pascale Foundation in Naples, Italy. He completed his medical degree with highest honors at Università Cattolica del Sacro Cuore, Rome, and specialized in Gynecology and Obstetrics at G. d’Annunzio University, Chieti-Pescara. He holds advanced qualifications in minimally invasive gynecologic surgery and statistical methods for clinical research, and has been awarded National Scientific Qualification as Associate Professor in Gynecology and Obstetrics. His research focuses on endometrial and ovarian cancers, fertility preservation, and innovative surgical and therapeutic techniques such as HIPEC and robotic surgery. Dr. Ronsini has authored over 90 scientific publications, participated in major European conferences, and contributes actively to research networks in gynecologic oncology. His work emphasizes improving oncological outcomes and surgical precision in women’s reproductive health.

• Gynecologic oncology
• Endometrial and ovarian cancer
• Hyperthermic intraperitoneal chemotherapy

1. Head Physician in Gynecologic Oncology at the National Cancer Institute IRCCS Pascale Foundation, Naples.

2. Collaborates with University of Campania “Luigi Vanvitelli” in clinical and academic teaching.

3. Obtained National Scientific Qualification as Associate Professor in Gynecology and Obstetrics (2023–2034).

4. Conducts advanced research on minimally invasive and fertility-preserving surgical techniques.

5. Guest speaker and participant at several international and Italian conferences (ESGO, SIGO, etc.).

6. Tutor and instructor for GESEA certification sessions in endoscopic gynecology.

7. Holds certifications in Minimal Invasive Gynecologic Surgery, Endoscopy, and Good Clinical Practice.

8. Member of several national and international gynecology research collaborations.

1. “Safety and Efficacy Outcomes of Robotic, Laparoscopic, and Laparotomic Surgery in Severely Obese Endometrial Cancer Patients: A Network Meta-Analysis” – Cancers, 2025

2. “Now or Later? The Role of Neoadjuvant Treatment in Advanced Endometrial Cancer: A Systematic Review” – Healthcare, 2024

3. “SIR-EN—New Biomarker for Identifying Patients at Risk of Endometrial Carcinoma” – Cancers, 2024

4. “Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm” – Annals of Surgical Oncology, 2023

5. “Robotic-Assisted Surgery for Endometrial Cancer: Outcomes in Indian Patients” – Journal of Robotic Surgery, 2024

6. “New Insights for Gynecological Cancer Therapies: From Molecular Mechanisms to Clinical Evidence” – Frontiers in Oncology, 2023

7. “Fertility-Sparing Treatment in Patients with Endometrial Cancer: A 24-Month Follow-Up Study” – Journal of Clinical Oncology, 2022

8. “Major Clinical Research Advances in Gynecologic Cancer: A 2023 Overview” – Gynecologic Oncology, 2024

9. “Minimally Invasive Surgery Versus Open Surgery in High-Risk Endometrial Cancer: A Meta-Analysis” – International Journal of Gynecological Cancer, 2023

10. “Adjuvant Therapy Options for Advanced Endometrial Cancer: Current Evidence and Future Directions” – Cancers, 2024